XRAY stock moves: recent performance in focus

DENTSPLY SIRONA (XRAY) has drawn fresh attention after recent share price gains, including a 3.5% move in the latest session and a 14.2% rise over the past month.

That latest move sits within a stronger recent pattern, with an 11% year to date share price return, but it follows a difficult stretch that left the 3 year total shareholder return at a 66.9% loss.

If DENTSPLY SIRONA’s recent rebound has you looking across healthcare and AI, this could be a good moment to scan 36 healthcare AI stocks

With XRAY trading at $12.51, a 57% estimated intrinsic discount and a 13% gap to the average analyst target sit alongside recent gains and a long 3 year loss. Is this a reset entry point, or is future growth already priced in?

Most Popular Narrative: 72.5% Undervalued

According to the most followed narrative, DENTSPLY SIRONA’s fair value of $45.50 sits well above the last close at $12.51, which frames the recent rebound in a very different light.

Dentsply Sirona operates in a corner of healthcare that rarely attracts hype but consistently demands precision. As one of the world’s largest dental equipment and consumables providers, the company sits upstream from patient demand, selling to dental practices rather than consumers. That position shapes everything about its business, from revenue stability to growth expectations.

This valuation story leans heavily on durable procedure volumes, recurring consumables, and the earnings power that could come with higher margins on that base. It raises the question of which assumptions bridge the gap between today’s price and that $45.50 fair value, and how long it might take to close that distance.

Result: Fair Value of $45.50 (UNDERVALUED)

However, you still need to weigh risks such as the recent net income loss of $598 million and the 3-year total shareholder return of negative 66.9%.

Next Steps

With mixed sentiment running through this story, it makes sense to move quickly, review the full picture yourself, and weigh both sides with 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If XRAY is on your radar, do not stop there. The right screen can surface opportunities you might otherwise miss and sharpen how you allocate your capital.

• Start with companies that appear mispriced relative to their fundamentals by running a focused search through 60 high quality undervalued stocks.
• Prioritize resilience and support a more stable portfolio by checking which names stand out in the 71 resilient stocks with low risk scores.
• Search for potential standouts before they attract wider attention by scanning the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.